PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Anti-diabetic effects have been reported for kawakawa, with identified natural products showing potential effects on glucose metabolism [PMID:32694996]
Kawakawa consumption led to differential abundances of nine postprandial miRNAs in healthy human volunteers, though no human studies on anti-inflammatory effects have been fully undertaken [PMID:39619950]
The amide piperdardine demonstrated cytotoxicity against HT 29 colon cancer cells with an IC50 of 14 μM [PMID:26039266]
Safety & adverse effects
Dosage & administration
Evidence summary
PubMed sources
- 1.PMID: 30572092 (2019) — Composition and safety evaluation of tea from New Zealand kawakawa (Piper excelsum). · Journal of ethnopharmacology
- 2.PMID: 26039266 (2015) — Cytotoxic Amides from Fruits of Kawakawa, Macropiper excelsum. · Planta medica
- 3.PMID: 32694996 (2020) — The Potential of Anti-Diabetic Rākau Rongoā (Māori Herbal Medicine) to Treat Type 2 Diabetes Mellitus (T2DM) Mate Huka: A Review. · Frontiers in pharmacology
- 4.PMID: 39619950 (2024) — Anti-inflammatory effects of kawakawa (Piper excelsum): An integrative mRNA-miRNA approach. · Food science & nutrition
- 5.PMID: 38389156 (2024) — Human Metabolism and Excretion of Kawakawa (Piper excelsum) Leaf Chemicals.